ERBB2 and breast cancer: Ding et al. synthesized polyethylene glycol (PEG) and poly (β-l-malic acid)-drug conjugates by covalently incorporating anti-HER2/neu peptide (AHNP) (trastuzumab-mimetic 12-merpeptide) for the treatment of HER2-positive breast cancer.